Connect with us

Press Releases

Horizon and Prevent Blindness Are Calling on the Thyroid Eye Disease (TED) Community to Put “Vision First”

It is by sharing their experiences, monitoring their symptoms and finding the right doctor.

mm

Published

on

(PRESS RELEASE) DUBLIN – In support of World Sight Day, Horizon Therapeutics plc (Nasdaq: HZNP) and Prevent Blindness launched a campaign that brings together the voices of the thyroid eye disease (TED) community to educate the public on how TED can damage vision and encourage people who are living with TED to put their vision first by sharing their experiences, monitoring their symptoms and finding the right doctor. World Sight Day is an internationally recognized awareness day designed to focus attention on blindness and vision impairment. This year’s dialogue emphasizes “Vision First,” with a call to the community to make vision a priority.

Now through Oct. 31, 2019, Horizon will donate $1 (up to $10,000) to Prevent Blindness every time someone texts “EYE” to 56512. The campaign also invites the TED community to visit www.MyTEDStory.com to share how they have seen TED affect vision – whether it be from experiencing it personally, or watching a friend, loved one or patient endure it. Select stories will be compiled and shared on social media to help people who are living with TED, healthcare professionals and the general public better understand the disease. Spotting the signs and symptoms of TED early can help decrease the chances of permanent eye damage. People who are at risk for TED, including those with Graves’ disease, are encouraged to pay attention to changes in their eyes – such as pain, redness, light sensitivity, bulging, blurry vision and double vision – and visit an ophthalmologist or oculoplastic surgeon to get an eye exam.

“According to the World Health Organization, approximately 80 percent of all vision impairment across the globe is considered avoidable – this statistic is both shocking and unacceptable,” said Jeff Todd, president and CEO, Prevent Blindness. “As a part of our sight-saving mission, we are thrilled to partner with Horizon to raise awareness about TED and inspire patients to actively monitor and successfully manage their symptoms.”

TED is a serious, progressive and vision-threatening autoimmune disease.1,2 TED begins with active TED that may last for up to three years, after which damage to the eyes can be irreversible.1,3 Common symptoms include light sensitivity, eye grittiness, bulging eyes and double vision, among others – all of which can reduce a person’s independence, ability to work and self-confidence.1,4 As TED progresses, it can cause long-term, irreversible damage. Effective management of TED requires early diagnosis and active monitoring to identify the best opportunity for medical intervention.1 Patients who suspect that they may have TED should visit an eye specialist, such as an ophthalmologist or oculoplastic surgeon, to have their eyes examined. To learn more about TED, visit the new Prevent Blindness web resource and visit www.ThyroidEyes.com to sign up to receive information about TED.

“At Horizon, we’ve made it our priority to better understand the needs of the TED community,” said Matt Flesch, vice president, communications and patient advocacy, Horizon. “Through conversations with patients, caregivers and healthcare professionals, we’ve heard how this disease can impair vision – making it difficult to do the things we often take for granted, like drive, walk up or down stairs alone and read. By working together with Prevent Blindness, we hope to multiply our efforts and reach even more people with the TED education and support they need to speak up and be good advocates for their eye health.”

To learn more about World Sight Day and other ways to get involved, visit the website for The International Agency for the Prevention of Blindness.

Advertisement

Advertisement

SPONSORED VIDEO

SPONSORED BY Essilor USA

See What Happens When Patients Try Varilux® Lenses for the First Time

Take the first step toward truly satisfying your patients.

Promoted Headlines

Press Releases

BHVI Collaborates with Global Experts to Launch the Myopia Education Program

The launch will see all three courses available in an anytime, anywhere format.

mm

Published

on

(PRESS RELEASE) BHVI launches their leading Myopia Education Program at the 2019 American Optometry Academy. The launch will see all three courses available in an anytime, anywhere format. This enables eyecare professionals to complete the program in their own time.

“We want to make our education program easily available to our community of professionals, so they have the flexibility to sign up and learn while still managing myopia in their busy practices” said Pamela Capaldi, Director of Professional Services with BHVI

BHVI has developed the program in collaboration from both BHVI and global experts. The use of interactive case studies, videos, polls and discussions gives participants an interactive, engaging and supported learning experience. Participants have a six-week time frame in which to complete these internationally accredited and recognized courses.

Uniquely, the BHVI Myopia Education Program comprehensively addresses managing Myopia from both a clinical and business practice perspective. The current program includes three key modules; 1. Managing Myopia – Changes the way you understand and treat myopia. 2. Complex Cases – Strategies and tools to help confidently manage more complex myopia cases. 3. The Business of Myopia –Maximize business results and grow your practice through managing myopia.

More about the Myopia Education Program can be found at education.bhvi.org

Continue Reading

Press Releases

Optometry Giving Sight Establishes New Board

Dr. Juan Carlos Aragón is the president.

mm

Published

on

(PRESS RELEASE) GOLDEN, CO – Optometry Giving Sight (OGS) announces that it has established a new Board of Directors to oversee the organization. Dr. Juan Carlos Aragón, president of CooperVision’s Specialty Eye Care Division, is the president of the new board. He previously served as Optometry Giving Sight’s chair of their Advisory Council U.S.A. and the Global Board for a several years.

Joining Dr. Aragón on the board are: Dr. Howard Purcell, president and CEO of the New England College of Optometry, Yvette Waddell, CEO of Brien Holden Vision Institute Foundation, Dr. Susan Cooper, former president of the World Council of Optometry and Dr. Earl Smith, former dean of the University of Houston College of Optometry. The OGS Board is meeting in Orlando during the Annual Meeting of the American Academy of Optometry and the World Congress of Optometry.

The past year has been one of transition for Optometry Giving Sight, as it is now focusing most of its fundraising priorities in the United States and Canada. The Brien Holden Vision Institute Foundation, one of the founding members of OGS, continues as a major implementing project partner. The World Council of Optometry, also a founding member of OGS, continues as a partner.

“We are very excited for Optometry Giving Sight’s future as we will be building on our strong history of supporting projects that bring accessible and sustainable eye care to those who are in need in the developing world. We look forward to enhancing our existing relationships in the vision care community and to establishing new partners throughout the industry” says Dr. Aragón.

Currently, Optometry Giving Sight is conducting its largest fundraising campaign of the year, the World Sight Day Challenge. Optometrists, practices and staff, vision care companies and others are all invited to participate in giving sight and hope to thousands of people around the world.

To learn more or make a donation please visit: https://www.givingsight.org/giving/world-sight-day-challenge.html

Continue Reading

Press Releases

Essilor Laboratories of America to Move Bell Optical to ‘State-of-the-Art Industrial Lab’ in December

It will be the largest integrated lab in the ELOA network.

mm

Published

on

(PRESS RELEASE) Essilor Laboratories of America announced that it is moving its Bell Optical Lab and building it out into a “state-of-the-art industrial lab” in Columbus, OH.

The Bell Columbus lab will be the largest integrated lab in the ELOA network and will co-locate with the company’s largest distribution center in the U.S., according to a press release. The move is occurring within the Columbus area, from 3671 Interchange Rd, Columbus, OH, to 2400 Spiegel Drive, Suite L, Groveport, OH.

“Bell Columbus will use the latest surfacing, coating, and finishing equipment with advanced sustainability standards to reduce waste and water usage, with faster processing – which supports the company’s efforts to be environmentally friendly and support the communities in which it serves,” the release states.

Employees from Bell Optical will move to the new location later this year, and the company will more than double the number of employees in Bell Columbus.

“Our lab network has a single ambition of improving lives by improving sight by serving customers, patients and consumers with the industry’s most technologically advanced products and highest service levels,” said Christophe Leger, Essilor of America’s senior vice president of operations and supply chain. “Moving Bell Columbus is the next step in our investment and vision of a truly integrated supply chain that leads the industry in delighting our customers and exceeding the expectations of their patients.”

The Bell Columbus Lab will be fully automated with “the most technologically advanced equipment and technology to deliver rapid turnaround times and the highest quality manufacturing of lenses for both Ohio customers and customers across the U.S.,” according to the release.

Continue Reading

Advertisement

Advertisement

Advertisement

Subscribe


BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Facebook

Most Popular